Registry Study for Talimogene Laherparepvec

CompletedOBSERVATIONAL
Enrollment

185

Participants

Timeline

Start Date

April 27, 2010

Primary Completion Date

September 23, 2021

Study Completion Date

September 23, 2021

Conditions
Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial
Interventions
OTHER

Information collection

Q3M Information collection

Trial Locations (59)

1011

Centre Hospitalier Universitaire Vaudois, Lausanne

1090

Universitaetsklinikum Allgemeines Krankenhaus Wien, Vienna

1205

Hopitaux Universitaires de Geneve, Geneva

5020

Landeskrankenhaus Salzburg, Salzburg

6720

Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar, Szeged

7000

Kantonsspital Graubuenden, Chur

7632

Pecsi Tudomanyegyetem Klinikai Kozpont, Pécs

8058

Universitaetsspital Zuerich, Zuerich Flughafen

11527

General Hospital of Athens Laiko, Athens

18547

Metropolitan Hospital, Athens

20014

Onkologikoa, Donostia / San Sebastian

20141

IRCCS Istituto Europeo di Oncologia, Milan

24127

Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo

27157

Wake Forest Baptist Health Medical Center, Winston-Salem

27599

University of North Carolina Chapel Hill, Chapel Hill

28041

Hospital Universitario 12 de Octubre, Madrid

29605

Greenville Health System Institute for Translational Oncology Research, Greenville

32117

Florida Hospital Memorial Division, Daytona Beach

32207

Baptist MD Anderson Cancer Center, Jacksonville

33140

Mount Sinai Comprehensive Cancer Center, Miami Beach

33612

H Lee Moffitt Cancer Center and Research Institute, Tampa

36604

University of South Alabama Mitchell Cancer Institute, Mobile

37232

Henry Joyce Cancer Center, Nashville

38138

The West Clinic PC dba West Cancer Center, Germantown

44093

Centre Hospitalier Universitaire de Nantes, Hôpital Hôtel Dieu, Nantes

44718

Gabrail Cancer Center, LLC, Canton

46014

Hospital General Universitario de Valencia, Valencia

46260

Investigative Clinical Research of Indiana, LLC, Indianapolis

53100

Azienda Ospedaliera Universitaria Senese Policlinico Le Scotte, Siena

53132

Wheaton Franciscan Healthcare, Franklin

54622

Bioclinic of Thessaloniki, Thessaloniki

55407

Allina Health System dba Virginia Piper Cancer Institute, Minneapolis

60068

Oncology Specialists SC, Park Ridge

63110

Saint Louis University Hospital, St Louis

69120

University Hospital, Heidelberg

72076

Universitätsklinikum Tübingen, Tübingen

72205

University of Arkansas for Medical Sciences, Little Rock

75230

Mary Crowley Cancer Research, Dallas

77030

University of Texas MD Anderson Cancer Center, Houston

80045

University of Colorado Cancer Center, Aurora

84107

Intermountain Medical Center, Murray

84112

University of Utah Huntsman Cancer Institute, Salt Lake City

92100

Hopital Ambroise Pare, Boulogne-Billancourt

95403

St Joseph Heritage Healthcare, Santa Rosa

97213

Providence Oncology and Hematology Care Eastside, Portland

115478

FSBI N N Blokhin Russian Oncology Research Center Ministry of Health of Russian Federation, Moscow

197758

FSBI Scientific and Research Oncology Institute named after N N Petrov, Saint Petersburg

07962

Morristown Medical Center, Morristown

08903

Rutgers Cancer Institute of New Jersey, New Brunswick

T2N 4N2

Tom Baker Cancer Centre, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

M5G 2M9

Princess Margaret Cancer Centre, Toronto

02-781

Narodowy Instytut Onkologii im Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Warsaw

0081

Wilgers Oncology Centre, Pretoria

03722

Yonsei University Health System Severance Hospital, Seoul

08036

Hospital Clinic i Provincial de Barcelona, Barcelona

SE1 9RT

Guys and St Thomas Hospital, London

SW3 6JJ

Royal Marsden Hospital, London

CH63 4JY

The Clatterbridge Cancer Centre NHS Foundation Trust, Metropolitan Borough of Wirral

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY